For Healthcare Professionals

OTIS Autoimmune Diseases in Pregnancy Project

clipboard-pencil

About the study

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Currently pregnant

EXCLUSION CRITERIA

    pin location

    Study Locations

    Enter your ZIP code/Postal code/PIN code to locate study sites near you:

    How to Apply


    Contact the study center to learn if this study is a good match for you.
    Phone iconCall 877-311-8972Email iconEmail Study Center

    Study’s details


    Contition

    Ankylosing Spondylitis,Crohn's Disease,Psoriasis,Psoriatic Arthritis,Rheumatoid Arthritis

    Age

    0+

    Participants needed

    925

    Est. Completion Date

    Oct 2026

    Treatment type

    Observational


    Sponsor

    University of California, San Diego

    ClinicalTrials.gov identifier

    NCT01797224

    Study number

    RA0023

    Understanding Clinical Trials


    Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
    Vector

    Interested?

    Sign up to save your favorites, 
    receive newsletters, resources, and alerts 
    about clinical trials related to your conditions of interest.